(Q53235983)

12 May 2018

title

Incidence and predictors of severe bleeding during warfarin treatment. (English)

1 reference

12 May 2018

1 reference

4

1 reference

12 May 2018

Jonatan D Lindh

1

object named as

Jonatan D Lindh

1 reference

12 May 2018

author name string

Lennart Holm

2

1 reference

12 May 2018

Marja-Liisa Dahl

3

1 reference

12 May 2018

Anders Rane

5

1 reference

12 May 2018

publication date

20 May 2007

1 reference

12 May 2018

Journal of Thrombosis and Thrombolysis

published in

1 reference

12 May 2018

volume

25

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

151-159

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s11239-007-0048-2

exact match

0 references

cites work

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-007-0048-2

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-007-0048-2

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

21 January 2018

1 reference

12 December 2020

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

1 reference

12 December 2020

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

12 December 2020

Internet based clinical trial protocols -- as applied to a study of warfarin pharmacogenetics

1 reference

12 December 2020

Oral anticoagulation and risk of death: a medical record linkage study

1 reference

12 December 2020

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

Several-fold increase in risk of overanticoagulation by CYP2C9 mutations

1 reference

12 December 2020

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Major bleeding after hospitalization for deep-venous thrombosis.

1 reference

12 December 2020

Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy

1 reference

12 December 2020

Gains and losses of warfarin therapy as performed in an anticoagulation clinic

1 reference

12 December 2020

Risk of major hemorrhage for outpatients treated with warfarin

1 reference

12 December 2020

Major bleeding complications in a specialized anticoagulation service

1 reference

12 December 2020

Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

12 December 2020

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

12 December 2020

Risks of oral anticoagulant therapy with increasing age.

1 reference

12 December 2020

Complications of long-term anticoagulation

1 reference

12 December 2020

The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

12 December 2020

Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization

1 reference

12 December 2020

Anticoagulant treatment of patients in Swedish primary health care. Safety aspects

1 reference

12 December 2020

[Survey of complications following treatment with anticoagulants. A computerized search for hemorrhagic complications completes manual reporting]

1 reference

12 December 2020

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

12 December 2020

10.1007/S11239-007-0048-2

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

17514429

1 reference

12 May 2018